SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001052918-20-000193
Filing Date
2020-08-06
Accepted
2020-08-06 14:47:39
Documents
3
Period of Report
2020-01-31

Document Format Files

Seq Description Document Type Size
1 AVRICORE HEALTH INC. FORM 6-K avricore6kjan2020.htm 6-K 7485
2 NEWS RELEASE ex99-1.htm EX-99 14694
3 ex991_1.jpg GRAPHIC 18561
  Complete submission text file 0001052918-20-000193.txt   49184
Mailing Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2
Business Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2 604-687-2038
Avricore Health Inc. (Filer) CIK: 0001355736 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-51848 | Film No.: 201081085
SIC: 2834 Pharmaceutical Preparations